Researchers from Weill Cornell Medicine Report Details of New Studies and Findings in the Area of Adverse Drug Reactions [Subgroup analysis of older patients treated within the randomized phase 3 doxorubicin versus doxorubicin plus evofosfamide ...]

MLA

“Researchers from Weill Cornell Medicine Report Details of New Studies and Findings in the Area of Adverse Drug Reactions [Subgroup Analysis of Older Patients Treated within the Randomized Phase 3 Doxorubicin versus Doxorubicin plus Evofosfamide ...].” Obesity, Fitness & Wellness Week, Mar. 2020, p. 6647. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.617548185&authtype=sso&custid=ns315887.

APA

Researchers from Weill Cornell Medicine Report Details of New Studies and Findings in the Area of Adverse Drug Reactions [Subgroup analysis of older patients treated within the randomized phase 3 doxorubicin versus doxorubicin plus evofosfamide ...]. (2020, March 21). Obesity, Fitness & Wellness Week, 6647.

Chicago

Obesity, Fitness & Wellness Week. 2020. “Researchers from Weill Cornell Medicine Report Details of New Studies and Findings in the Area of Adverse Drug Reactions [Subgroup Analysis of Older Patients Treated within the Randomized Phase 3 Doxorubicin versus Doxorubicin plus Evofosfamide ...],” March 21. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.617548185&authtype=sso&custid=ns315887.